COVID-19 can affect joints during the initial infection and for months afterward. Roughly a quarter of people who catch the virus report joint pain at some point during or after their illness, and joint pain ranks among the most common long COVID complaints. The reasons range from the body’s inflammatory overreaction to possible autoimmune triggers, and the joint symptoms themselves can look strikingly similar to established rheumatic diseases. Understanding when this pain appears, why it happens, and what to do about it matters whether you are dealing with a new ache after a recent infection or lingering stiffness that will not go away.
Joint Pain During Acute Infection
Joint pain, or arthralgia, shows up during the active phase of COVID-19 more often than many people realize. In a cohort of 294 hospitalized patients, about 30% reported musculoskeletal complaints overall, with nearly 6% specifically reporting arthralgia as a distinct symptom separate from the more common generalized body aches and muscle soreness. The arthralgia tended to be more severe and appeared at variable times during the illness, while general body aches and muscle pain usually tracked alongside fever and respiratory symptoms.1PubMed Central. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms
A larger national survey of over 1,000 confirmed cases found that about 27% reported arthralgia at some point during or after their infection, while more than half reported muscle pain. What stood out was that roughly 10% developed arthralgia only after their acute COVID symptoms had cleared, suggesting the joint involvement is not always part of the initial sick phase but can emerge as a delayed reaction.2PubMed Central. Patterns of Viral Arthropathy and Myalgia Following COVID-19: A Cross-Sectional National Survey
The distinction matters practically. If your joints start hurting during the fever-and-cough stage, that tracks with how many viral infections behave. But if joint pain appears a week or two after you thought you were getting better, it is more likely tied to the immune aftershocks of the infection rather than the virus itself tearing through your system.
When Joint Pain Lingers Into Long COVID
For a subset of people, joint pain does not resolve when the infection ends. A systematic review and meta-analysis tracking post-COVID pain found that the prevalence of joint pain ranged from about 5% to 12% at various follow-up points during the first year after infection.3PubMed. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis Another systematic review found that post-acute arthralgia ranged even more widely, from 2% to 65% depending on the study population and how far out researchers looked, anywhere from four weeks to twelve months post-infection.4PubMed Central. Post-Acute COVID-19 Joint Pain and New Onset of Rheumatic Musculoskeletal Diseases: A Systematic Review
That wide range reflects differences in study design and patient populations, but the pattern is consistent: joint pain is one of the top symptoms reported by people with long COVID. One analysis of long COVID symptom prevalence placed joint pain at about 27%, trailing only fatigue and shortness of breath.5Trends in Endocrinology & Metabolism. Mechanisms of Long COVID – Section: Prevalence and manifestations of Long COVID
A cross-sectional study focused specifically on new-onset chronic musculoskeletal pain in long COVID patients found that the pain was typically widespread and continuous, and that it was worst in the joints rather than in muscles or other soft tissues.6PubMed Central. Clinical Characterization of New-Onset Chronic Musculoskeletal Pain in Long COVID: A Cross-Sectional Study This is not the occasional twinge people describe after a bad flu. For some, it is persistent pain that interferes with daily life and resembles what you would see in a chronic rheumatic condition.
Why COVID Targets the Joints
There is no single mechanism behind COVID-related joint pain. Researchers have identified at least three pathways, and they can overlap in the same person.
The first is the inflammatory cascade. Severe COVID-19 can trigger what is sometimes called a cytokine storm, where the immune system releases a flood of inflammatory signaling molecules. Patients show elevated levels of several pro-inflammatory cytokines, including IL-1, IL-6, and TNF-α, some of which correlate with how sick someone gets.7PubMed Central. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy These same molecules are major drivers of joint inflammation in conditions like rheumatoid arthritis. When the body is awash in them, joints can become collateral damage even without the virus directly infecting joint tissue.
The second pathway is direct viral invasion of the joint. This was once considered unlikely, but case reports have now documented SARS-CoV-2 genetic material inside synovial fluid, the lubricating liquid within joint capsules. One early case report detected viral RNA in synovial fluid from an inflamed joint.8PubMed Central. A case of SARS-CoV-2-associated arthritis with detection of viral RNA in synovial fluid A subsequent study examining five patients with knee effusion and positive COVID tests found viral RNA in the synovial tissue of one patient.9PubMed. Examination of SARS-CoV-2 RNA in joint synovial fluid of patients with COVID-19 and acute knee arthritis These findings are rare, which suggests direct viral infection of joints is not the main driver for most people, but it does happen.
The third pathway involves autoimmune mechanisms. Parts of the SARS-CoV-2 virus bear structural resemblance to certain human proteins, a phenomenon called molecular mimicry. Researchers have identified hundreds of pairs where viral and human protein fragments are similar enough that the immune system, primed to attack the virus, could mistakenly target the body’s own tissues. This has been linked to several autoimmune disorders, including conditions that affect the joints.10PubMed Central. Molecular Mimicry Impact of the COVID-19 Pandemic: Sequence Homology Between SARS-CoV-2 and Autoimmune Diseases Epitopes
Reactive Arthritis After COVID
Reactive arthritis is a well-known response to certain infections, where joint inflammation flares up days to weeks after a bacterial or viral illness. COVID-19 has added itself to the list of triggers. A systematic review of 27 case reports, covering 54 patients, found that reactive arthritis symptoms appeared on average about three weeks after infection. The arthritis usually affected one or a few joints rather than many, and the good news is that symptoms resolved within days in nearly all reported cases. At follow-up, patients were either asymptomatic or had only mild lingering symptoms.11PubMed Central. Reactive arthritis following COVID-19 current evidence, diagnosis, and management strategies
A separate analysis found that this post-COVID arthritis typically showed up 4 to 44 days after infection, usually affecting one joint or a small cluster of joints. In the cases examined, the arthritis responded well to common anti-inflammatory treatments and steroid injections.12PubMed Central. Post-Corona-Virus-Disease‑19 arthritis. Manifestation under the clinical picture of a reactive arthritis This form of joint involvement is the most benign version of what COVID can do. It is uncomfortable but temporary, and standard treatments work.
Can COVID Trigger Rheumatoid Arthritis?
This is the question that concerns rheumatologists most. Unlike reactive arthritis, which burns out on its own, rheumatoid arthritis is a chronic condition that requires ongoing management. There is growing evidence that COVID-19 can be the spark that sets off rheumatoid arthritis in people who were genetically predisposed but had never developed the disease.
A systematic review of cases documented rheumatoid arthritis emerging after COVID-19 infection, with the authors concluding that the infection appeared to trigger the disease in individuals who were already genetically susceptible.13PubMed Central. COVID-19-Induced Rheumatoid Arthritis: Case Series and Systematic Review of the Literature A case series from a post-COVID follow-up clinic confirmed both rheumatoid arthritis and reactive arthritis occurring in the same patient population.14American Journal of Case Reports. Inflammatory Arthritis After COVID-19: A Case Series
More compellingly, a population-level study found that the incidence rate of rheumatoid arthritis and related inflammatory diagnoses increased in people after COVID-19 during 2020 to 2022. Women in their fifties were at the greatest risk, and most new cases appeared within the first year following infection.15Autoimmunity Reviews. Increased incidence of rheumatoid arthritis after COVID-19 The evidence is not yet definitive enough to call COVID a proven cause of rheumatoid arthritis, but the signal is strong enough that clinicians are watching for it.
How COVID-Related Arthritis Looks on Imaging
When doctors see joint inflammation in someone who recently had COVID, the clinical picture can be confusingly similar to rheumatoid arthritis. In a case series of five patients, musculoskeletal ultrasound showed synovitis in the small joints of the hands and wrists bilaterally, a pattern that closely mimics rheumatoid arthritis. Interestingly, these patients tested negative for the typical rheumatoid factor and anti-CCP antibodies, making them “seronegative,” which adds an extra layer of diagnostic challenge.16PubMed Central. COVID-19: An Emerging Culprit of Inflammatory Arthritis – Section: 3. Clinical Course and Therapeutic Intervention
One distinguishing feature on ultrasound is that COVID-related arthritis tends to show synovial thickening and increased blood flow consistent with active inflammation, but erosions, the bone damage characteristic of established rheumatoid arthritis, are rarely seen.17Revista Colombiana de ReumatologÃa. Utility of musculoskeletal ultrasound (MSK-US) in the diagnosis of COVID-19 related arthritis – Section: Musculoskeletal ultrasound in COVID-19-related arthritis The absence of erosions is a clue that the inflammation is relatively new rather than part of a long-smoldering autoimmune process. For clinicians, ultrasound has become a useful tool for distinguishing post-COVID joint inflammation from a pre-existing rheumatic disease that simply happened to surface around the same time.
Who Is at Higher Risk for Post-COVID Joint Problems
Not everyone who catches COVID develops joint symptoms. Several risk factors make it more likely.
Being female appears to be the most consistent predictor. A multicenter study of hospitalized COVID survivors found that women had about 35% higher odds of developing musculoskeletal post-COVID pain. Having a history of musculoskeletal pain before infection, experiencing muscle pain and headaches as acute COVID symptoms, and spending more days in the hospital also increased the odds.18Pain. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study A review of the broader literature echoed the female sex finding and added that higher body mass index appeared to be a risk factor, while age and ethnicity did not show a clear association.19PubMed Central. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID
The takeaway here is somewhat counterintuitive. You might expect older people or those with more severe initial illness to be most at risk, but the data suggest that the profile of the person matters more than the severity of the infection itself. A woman in her forties with a history of occasional back pain and a moderate COVID case may be more vulnerable than an older man who was hospitalized for weeks.
Flare-Ups in People Who Already Have Rheumatic Disease
If you already live with a condition like rheumatoid arthritis, lupus, or another autoimmune joint disease, COVID-19 can make it worse. A prospective study found that 41% of patients with pre-existing autoimmune rheumatic diseases reported a disease flare after COVID-19. Their self-reported disease activity scores were significantly worse after the infection compared to before it.20PubMed Central. DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
Part of the problem is practical. Many disease-modifying drugs used for rheumatic conditions suppress the immune system, and patients sometimes paused or reduced their medications during or after COVID-19 out of concern about immune suppression during an active infection. That disruption alone can trigger a flare. But the immune activation from the virus itself also appears to independently worsen the underlying condition. If you have a pre-existing rheumatic disease and contract COVID, working closely with your rheumatologist on medication management is especially important.
Treatment Options for COVID-Related Joint Pain
There is no COVID-specific joint pain medication. Treatment follows the same general approach used for other inflammatory joint conditions, with some adjustments based on the clinical context.
For mild to moderate joint pain, acetaminophen (paracetamol) is considered the first-line option, particularly during active COVID-19 when fever and muscle pain are also present. NSAIDs like ibuprofen are widely used and have been shown to be helpful, despite early pandemic concerns about their safety in COVID, which were largely unfounded. Systemic corticosteroids are reserved for severe cases and are not recommended as routine joint pain treatment. For more intense pain, opioids are a last resort, and if they are used, buprenorphine is preferred because of its more limited impact on immune function.21Frontiers in Pain Research. A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients With COVID-19 – Section: Treatment
For reactive arthritis that develops after COVID clears, the standard toolkit works well: NSAIDs and sometimes a short course of steroids, either by mouth or injected directly into the affected joint. As noted in the reactive arthritis data, most cases resolve completely with these measures.12PubMed Central. Post-Corona-Virus-Disease‑19 arthritis. Manifestation under the clinical picture of a reactive arthritis
Non-drug approaches also play a genuine role. Physical therapy has been identified as an important part of managing long COVID broadly, helping to improve symptoms and overall physical function in people dealing with persistent pain and deconditioning.22PubMed Central. Long COVID and Physical Therapy: A Systematic Review Graded exercise, stretching, and joint mobility work can help break the cycle of pain leading to inactivity leading to stiffness leading to more pain, which is a familiar spiral for anyone who has dealt with chronic joint issues of any origin.
The Gut Connection to Post-COVID Joint Pain
One less obvious pathway connecting COVID to joint problems runs through the gut. SARS-CoV-2 enters cells using the ACE2 receptor, which is abundant in the lining of the intestine. When the virus downregulates this receptor, it disrupts the gut’s microbial balance. This dysbiosis has been linked to a range of long COVID symptoms, including joint pain.23PubMed Central. Role of Gut Microbiota in Long COVID: Impact on Immune Function and Organ System Health
The gut-joint connection is not unique to COVID. Rheumatologists have long recognized that disruptions in gut bacteria are associated with inflammatory arthritis, and several autoimmune joint diseases are linked to intestinal permeability and microbial imbalance. COVID may simply be exploiting a pathway that already exists. This is still an active area of research, and there are no specific gut-targeted therapies proven to help with post-COVID joint pain, but it helps explain why some people develop joint symptoms even when the virus never directly reaches their joints.
Can COVID Vaccines Cause Joint Symptoms?
Joint pain has been reported as an uncommon side effect of COVID-19 vaccination, and a systematic review of case reports found a temporal link between vaccination and new-onset arthritis. The majority of cases appeared within a week of receiving a dose. However, even within the reviewed cases, the arthritis was described as relatively rare and the joint symptoms improved or resolved completely with standard treatment. The authors characterized it as a likely transient immune response to the vaccine rather than a lasting adverse effect.24PubMed Central. New-Onset Arthritis Following COVID-19 Vaccination: A Systematic Review of Case Reports
A separate report documented inflammatory arthritis occurring about ten days after vaccination, noting that the majority of reported cases resolve within a week, though a small number of patients experienced symptoms lasting beyond three weeks.25PubMed Central. Inflammatory Arthritis Associated with COVID-19 Vaccination The mechanism is thought to be the same molecular mimicry and immune activation that drives post-infection arthritis, just at a much lower intensity because the vaccine exposes you to a fragment of the virus rather than the whole thing.
This does not change the risk-benefit calculation for vaccination. Post-infection arthritis is more common, more severe, and more likely to become chronic than post-vaccination arthritis. But if you develop sudden joint swelling and pain shortly after a COVID vaccine, it is worth mentioning to your doctor so they can distinguish it from other causes and treat it appropriately.
How Post-COVID Joint Pain Affects Daily Life
The numbers on prevalence can feel abstract until you consider what chronic joint pain actually does to someone’s day-to-day functioning. A cross-sectional survey of COVID survivors found that those with lingering pain, including joint pain, scored significantly lower across all quality-of-life domains compared to people who recovered without lasting symptoms. Having multiple long COVID symptoms or a longer duration of symptoms made the gap even wider.26BMC Infectious Diseases. Clinical presentation of post-COVID pain and its impact on quality of life in long COVID patients: a cross-sectional household survey of SARS-CoV-2 cases in Bangladesh
Joint pain interferes with sleep, exercise, work, and social activity. Because post-COVID joint pain is often widespread and continuous rather than isolated to one joint, it can feel more like living with a chronic pain condition than recovering from an acute illness. People who were previously active sometimes find themselves unable to exercise at their former level, which creates a cascade effect on cardiovascular fitness, mental health, and weight management. The loss of function can be especially frustrating because, from the outside, the person looks healthy and the original infection may have seemed mild.
For people in this situation, the combination of medical treatment and structured physical rehabilitation offers the best path forward. Waiting it out without intervention tends to prolong the cycle, while aggressive early management with anti-inflammatories and guided exercise appears to yield better functional outcomes. If joint symptoms persist beyond a few weeks after a COVID infection, getting evaluated by a rheumatologist rather than simply treating the pain symptomatically is a reasonable move, given the possibility of an emerging autoimmune condition that benefits from early intervention.